Chaturaka Rodrigo

Researcher, Physician, Traveller

[Chaturaka Rodrigo @chaturod]

Is resitance to anti-HCV drugs "real"? After a decade of treatment, a collboration of scientists and clinicians from 17 countries collated their data for the most comprehensive answer to-date for this question.
#HCV #EASL #SHARED #JHEPreports
https://t.co/AA0jHcI2nI

[Chaturaka Rodrigo @chaturod]

A detailed analysis of how Hepatitis C virus variants emerge and diminish within a single infected patient overtime - a feat possible with tools we developed over the last 5 years #ONT #Oxfordnanopore #NanoQ #HCV
https://t.co/3yvfzP6Tjs

[Chaturaka Rodrigo @chaturod]

More severe COVID may also lead to better immunity, at least up to 12 months post-infection - Our latest publication (NB - This is pre-Omicron data)
#COVID19
https://t.co/X3JJrnswCc

[Chaturaka Rodrigo @chaturod]

Data on post-thrombolysis outcomes for patients in South Asian countries are scanty at best. We recently published some much needed data from Sri Lanka on this.
https://t.co/mzXZ3bE45k

[Chaturaka Rodrigo @chaturod]

How common is plasma leakage in dengue? An all important question for which the answer is not straight forward - we discuss the reasons here in our latest work. #denguefever #Colombodenguestudy
https://t.co/s0oXD5AQEN

[Chaturaka Rodrigo @chaturod]

Is it cheaper to exclude a diagnosis of dengue upfront, than treat everyone on clinical suspicion?

-Depends on who is testing

#denguefever #Colombodenguestudy
#PLOSONE: Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study https://t.co/8GC1uVxhIv

[Chaturaka Rodrigo @chaturod]

SHARED: An International Collaboration to Unravel Hepatitis C Resistance https://t.co/7ckWMB6gJq ##mdpiviruses via @VirusesMDPI
A global collaboration for tracking resistant mutations in hepatitis C virus against directly acting antivirals
#HCV #antivirals

[Chaturaka Rodrigo @chaturod]

Check out "Viral Hepatitis: improving lives with medical research - a panel discussion" https://t.co/LCqr5Cww7w @Eventbrite

[Chaturaka Rodrigo @chaturod]

Check out the free event "Viral Hepatitis: improving lives with medical research - a panel discussion" https://t.co/LCqr5Cww7w @Eventbrite

[Chaturaka Rodrigo @chaturod]

Developing tools to understand how HCV, a carcinogenic virus tackles the human immune system successfully (on most occassions)
#HCV #antibodies #Immunity https://t.co/r6SJzYPMUr

[Chaturaka Rodrigo @chaturod]

For how long does COVID-19 immunity last after natural infection? At least for 6 months and possibly more, driven by memory B cells (Our latest paper, hot off the press) #COVID19 https://t.co/PoheTEyiGI

[Chaturaka Rodrigo @chaturod]

Multiple genomic variants of RNA viruses exist in a single infected person. Scientists assume a representative sequence per host as these variants cannot be sequenced in whole……until now; with @PDawgzGG @martinalexsmith @DrKirston @nasirriaz
https://t.co/PkmGnjMm8D

[VIPR BRC @vipr_db]

Adikari et al. develop a methodology to sequence near full-length Dengue virus genomes as intact molecules. Thanks for using @vipr_db! @chaturod @thiruni1 @PDawgzGG @UNSW
https://t.co/9yqXonIsdA

[Martin Smith @martinalexsmith]

A pre-pandemic Dengue virus sequencing project we were involved in was recently published. Led by @chaturod @thiruni1 & @nasirriaz with help from the magical pipette of @DrKirston
https://t.co/ETOMlV6Nm4

[Chaturaka Rodrigo @chaturod]

Severity of fatigue after an acute infection may be influenced by patient genetics -our latest work
https://t.co/yA2Bpkb7Xb

[Chaturaka Rodrigo @chaturod]

Our new method makes it much easier to generate dengue genomes. There is also a cool new tool to identify within-host variants #Dengue #Colombodenguestudy #ONT
https://t.co/4akqlCQvdT

[Chaturaka Rodrigo @chaturod]

#mdpiviruses Tenth Scientific Biennial Meeting of the Australasian Virology Society—AVS10 2019 @VirusesMDPI

[Chaturaka Rodrigo @chaturod]

My article is featured on the @ResearchGate #COVID19 community page. Read it here: https://t.co/nae7WfZN9j

[Chaturaka Rodrigo @chaturod]

@PDawgzGG He also tweets now

[Chaturaka Rodrigo @chaturod]

A major obstacle for vaccine development in hepatitis C is the variability of the virus genome. We have found that this variability differs based on the type virus and a persons genetic make up
#HCV #viruses #shannonentropy #cirrhosis
https://t.co/owcZGUAPAM